These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29752653)

  • 1. Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation.
    Lao PJ; Handen BL; Betthauser TJ; Cody KA; Cohen AD; Tudorascu DL; Stone CK; Price JC; Johnson SC; Klunk WE; Christian BT
    Brain Imaging Behav; 2019 Apr; 13(2):345-353. PubMed ID: 29752653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI.
    Akamatsu G; Ikari Y; Ohnishi A; Nishida H; Aita K; Sasaki M; Yamamoto Y; Sasaki M; Senda M
    Phys Med Biol; 2016 Aug; 61(15):5768-80. PubMed ID: 27405579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification.
    Presotto L; Iaccarino L; Sala A; Vanoli EG; Muscio C; Nigri A; Bruzzone MG; Tagliavini F; Gianolli L; Perani D; Bettinardi V
    Neuroimage Clin; 2018; 20():153-160. PubMed ID: 30094164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome.
    Zammit MD; Tudorascu DL; Laymon CM; Hartley SL; Zaman SH; Ances BM; Johnson SC; Stone CK; Mathis CA; Klunk WE; Cohen AD; Handen BL; Christian BT
    Neuroimage; 2021 Mar; 228():117728. PubMed ID: 33421595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
    Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Johnson SC; Klunk WE; Christian BT
    J Alzheimers Dis; 2018; 61(2):631-644. PubMed ID: 29254096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.
    Handen BL; Cohen AD; Channamalappa U; Bulova P; Cannon SA; Cohen WI; Mathis CA; Price JC; Klunk WE
    Alzheimers Dement; 2012 Nov; 8(6):496-501. PubMed ID: 23102120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET.
    Hsiao IT; Huang CC; Hsieh CJ; Wey SP; Kung MP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):908-20. PubMed ID: 23412134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
    Rafii MS; Lukic AS; Andrews RD; Brewer J; Rissman RA; Strother SC; Wernick MN; Pennington C; Mobley WC; Ness S; Matthews DC;
    J Alzheimers Dis; 2017; 60(2):439-450. PubMed ID: 28946567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar β-amyloid in adults with down syndrome: safety, acceptability, and feasibility.
    Landt J; D'Abrera JC; Holland AJ; Aigbirhio FI; Fryer TD; Canales R; Hong YT; Menon DK; Baron JC; Zaman SH
    Arch Neurol; 2011 Jul; 68(7):890-6. PubMed ID: 21403005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial normalization and quantification approaches of PET imaging for neurological disorders.
    Zhang T; Wu S; Zhang X; Dai Y; Wang A; Zhang H; Tian M
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3809-3829. PubMed ID: 35624219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
    Edison P; Carter SF; Rinne JO; Gelosa G; Herholz K; Nordberg A; Brooks DJ; Hinz R
    Neuroimage; 2013 Apr; 70():423-33. PubMed ID: 23261639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.
    Neale N; Padilla C; Fonseca LM; Holland T; Zaman S
    Neuroimage Clin; 2018; 17():263-271. PubMed ID: 29159043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of MRI and cannabinoid type 1 receptor PET templates constructed using DARTEL for spatial normalization of rat brains.
    Kronfeld A; Buchholz HG; Maus S; Reuss S; Müller-Forell W; Lutz B; Schreckenberger M; Miederer I
    Med Phys; 2015 Dec; 42(12):6875-84. PubMed ID: 26632044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.
    Doran E; Keator D; Head E; Phelan MJ; Kim R; Totoiu M; Barrio JR; Small GW; Potkin SG; Lott IT
    J Alzheimers Dis; 2017; 56(2):459-470. PubMed ID: 27983553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.
    Ito H; Shinotoh H; Shimada H; Miyoshi M; Yanai K; Okamura N; Takano H; Takahashi H; Arakawa R; Kodaka F; Ono M; Eguchi Y; Higuchi M; Fukumura T; Suhara T
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):745-54. PubMed ID: 24233004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A standardized method for the construction of tracer specific PET and SPECT rat brain templates: validation and implementation of a toolbox.
    Vállez Garcia D; Casteels C; Schwarz AJ; Dierckx RA; Koole M; Doorduin J
    PLoS One; 2015; 10(3):e0122363. PubMed ID: 25823005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of selective positron emission tomography template method for spatial normalization of amyloid imaging with 11C-Pittsburgh Compound B.
    Chae SY; Kim HO; Oh M; Lee DY; Jin S; Oh SJ; Lee JH; Na DL; Seo SW; Lee CS; Kim JS
    J Comput Assist Tomogr; 2014; 38(6):924-9. PubMed ID: 24979265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR-less surface-based amyloid assessment based on 11C PiB PET.
    Zhou L; Salvado O; Dore V; Bourgeat P; Raniga P; Macaulay SL; Ames D; Masters CL; Ellis KA; Villemagne VL; Rowe CC; Fripp J;
    PLoS One; 2014; 9(1):e84777. PubMed ID: 24427295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.